Bictegravir-Tenofovir alafenamide-Emtricitabine Biktarvy
Darunavir-Cobicistat-Tenofovir alafenamide-Emtricitabine Symtuza
Dolutegravir-Abacavir-Lamivudine Triumeq
Dolutegravir-Lamivudine Dovato
Dolutegravir-Rilpivirine Juluca
Doravirine-Tenofovir DF-Lamivudine Delstrigo
Efavirenz-Tenofovir DF-Emtricitabine Atripla
Elvitegravir-Cobicistat-Tenofovir alafenamide-Emtricitabine Genvoya
Elvitegravir-Cobicistat-Tenofovir DF-Emtricitabine Stribild
Rilpivirine-Tenofovir alafenamide-Emtricitabine Odefsey
Rilpivirine-Tenofovir DF-Emtricitabine Complera
Fostemsavir Rukobia
Ibalizumab Trogarzo
Maraviroc Selzentry
Dolutegravir Tivicay
Raltegravir Isentress
Tenofovir alafenamide-Emtricitabine Descovy
Tenofovir DF-Emtricitabine Truvada and Multiple Generics
Doravirine Pifeltro
Efavirenz Sustiva
Etravirine Intelence
Rilpivirine EdurantNot Found!
Unfortunately the page you requested was not found.
Perhaps you can find what you were looking for on this page.
Antiretroviral Therapy
You are just a few steps away from free CE credits!
1
Sign in or Register
A free account is required.
2
Study the Material
An entire Cc section, or just a few topics at a time.
3
Take the CE Quiz
5 questions covering the topics in each Cc section.
4
Claim CE Credit
Free CNE and Free CME available!
Section Navigation
Section Navigation
- Lesson 5 Overview
Evaluation and Management of Virologic Failure - 0%Topic 1
IntroductionActivities- 0%Topic 2
Definition of Terms Related to Virologic ResponsesActivities- 0%Topic 3
Causes of Virologic FailureActivities- 0%Topic 4
Approach to Detectable HIV RNA LevelsActivities- 0%Topic 5
HIV Drug Resistance AssaysActivities- 0%Topic 6
Indications for HIV Drug-Resistance TestingActivities- 0%Topic 7
Interpretation of Drug-Resistance AssaysActivities- 0%Topic 8
Nucleoside Reverse Transcriptase Inhibitor ResistanceActivities- 0%Topic 9
Non-Nucleoside Reverse Transcriptase Inhibitor ResistanceActivities- 0%Topic 10
Integrase Strand Transfer Inhibitor ResistanceActivities- 0%Topic 11
Protease Inhibitor ResistanceActivities- 0%Topic 12
Entry Inhibitor ResistanceActivities- 0%Topic 13
Capsid InhibitorsLesson 5 Survey: Evaluation and Management of Virologic Failure
Sign in Required to Track Progress
To access the Topics in this Lesson, you must Sign In or Register Required for CNE/CME
Signing in will track your progress and allow you to claim CE credits.
No sign-in for Quick Reference Views
You can find all of the topics from this module in the openly accessible
Quick ReferenceFunded byHealth Resources and Services Administration (HRSA)Created at University of WashingtonAn AETC ProgramPart of IDEA PlatformCME provided byUniversity of Alabama BirminghamCNE approved byOregon Nurses AssociationCopyright © 2025 National HIV CurriculumThe Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS) provided financial support for this website. The award provided 100% of total costs and totaled $1,172,994. The contents are those of the author. They may not reflect the policies of HRSA, HHS, or the U.S. Government.Since you've received 80% or better on this quiz, you may claim continuing education credit.
You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.
Current Version: nhivc-master-d52d2330-2025-09-05-201745 - 0%Topic 2